GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jiangsu Lianhuan Pharmaceutical Co Ltd (SHSE:600513) » Definitions » Construction In Progress

Jiangsu Lianhuan Pharmaceutical Co (SHSE:600513) Construction In Progress : ¥108 Mil (As of Mar. 2025)


View and export this data going back to 2003. Start your Free Trial

What is Jiangsu Lianhuan Pharmaceutical Co Construction In Progress?

Jiangsu Lianhuan Pharmaceutical Co's quarterly construction in progress increased from Sep. 2024 (¥53 Mil) to Dec. 2024 (¥100 Mil) and increased from Dec. 2024 (¥100 Mil) to Mar. 2025 (¥108 Mil).

Jiangsu Lianhuan Pharmaceutical Co's annual construction in progress increased from Dec. 2022 (¥68 Mil) to Dec. 2023 (¥226 Mil) but then declined from Dec. 2023 (¥226 Mil) to Dec. 2024 (¥100 Mil).


Jiangsu Lianhuan Pharmaceutical Co Construction In Progress Historical Data

The historical data trend for Jiangsu Lianhuan Pharmaceutical Co's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jiangsu Lianhuan Pharmaceutical Co Construction In Progress Chart

Jiangsu Lianhuan Pharmaceutical Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Construction In Progress
Get a 7-Day Free Trial Premium Member Only Premium Member Only 366.68 184.84 68.31 225.81 100.22

Jiangsu Lianhuan Pharmaceutical Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 255.58 265.85 53.22 100.22 107.99

Jiangsu Lianhuan Pharmaceutical Co Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.


Jiangsu Lianhuan Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
No. 9, Jiankang 1st Road, Yangzhou Bio-Health Industry Park, Jiangsu Province, Yangzhou, Jiangsu, CHN, 225127
Jiangsu Lianhuan Pharmaceutical Co Ltd is engaged in producing benign prostatic hyperplasia, allergy and cardiovascular drugs. In the field of pharmaceutical manufacturing, the company's main products include several series such as urinary system drugs, antihistamines, cardiovascular drugs, steroid hormones, antibiotics, etc., covering chemical raw materials and injections, solid preparations and various drug dosage forms, including the national first-class new drug Apelite Tablets (Chuanliu).
Executives
Wang Chun Yuan Supervisors
Chu Qing Song senior management
Xia Chun Lai Director
Pan He Ping Directors, senior managers
Niu Ben senior management
Wu Wen Ge Director
Zhu Yong Jun senior management
Qian Zhen Hua Director
Shen Yi senior management
Huang Wen Tao senior management
Zhou Jun senior management
Tu Bin senior management
Qin Xiong Jian senior management

Jiangsu Lianhuan Pharmaceutical Co Headlines

No Headlines